New study eyes Tirzepatide's hidden impact on joints and heart

NCT ID NCT07567378

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This observational study in Mexico will follow 30 adults already taking tirzepatide for conditions like diabetes or obesity. Researchers will use MRI scans of the knees, CT scans of the heart, and body composition tests to see how the drug affects cartilage, heart fat, and overall health. The goal is to understand whether tirzepatide's benefits on joints occur independently of weight loss.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
tirzepatide
What this could lead to
If successful, this study could reveal how tirzepatide impacts joint health and heart fat, potentially guiding future treatments for arthritis and heart disease.
What could go wrong
This is a small, early observational study with only 30 participants, so results may not apply widely. It does not test tirzepatide directly, only observes people already taking it.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • IMSS Clínica Río Magdalena

    Mexico City, Mexico City, 01090, Mexico

More trials for these conditions

Other studies related to the condition(s) this trial covers.